|
Number of subjects
|
30
|
18
|
|
Age >60 years
|
14/30 (47%)
|
4/18 (22%)
|
|
Male (%)
|
21 (70%)
|
12 (67%)
|
|
Fatty liver risk factor (Alcohol or metabolic)
| | |
|
Self-declared alcohol consumption at risk*
|
8/30 (27%)
|
2/18 (11%)
|
|
Elevated Carbohydrate Deficient Transferin (>1.6%)
|
9/30 (30%)
|
12/18 (67%) (P = 0.01)
|
|
Alcohol at risk (either consumption or CDT)
|
16/30 (53%)
|
13/18 (72%)
|
|
BMI >= 27.0
|
10/30 (33%)
|
4/18 (22%)
|
|
Metabolic factor of ATP-III classification (at least one)
| | |
|
Glucose >= 6.1 mmol/L or diabetes treatment
|
7/30 (23%)
|
2/18 (11%)
|
|
Central obesity waist >102 male >88 female
|
7/30 (23%)
|
2/18 (11%)
|
|
Triglycerides >= 1.7 mmol/L or fibrate treatment
|
8/30 (27%)
|
2/17 (12%)
|
|
Hypertension or treatment
|
12/30 (40%)
|
2/18 (11%) (P = 0.05)
|
|
HDL-cholesterol <1.03 mmol/L male <1.29 mmol/L female
|
2/30 (7%)
|
1/18 (6%)
|
|
Steatosis predicted by SteatoTest
|
7/30 (23%)
|
3/17 (18%)
|
|
HCV antibody positive
|
0/30 (0%)
|
0/18 (0%)
|
|
HIV antibody positive
|
0/30 (0%)
|
0/18 (0%)
|
|
HBsAg antigen positive
|
1/30 (3%)
|
0/18 (0%)
|
